期刊文献+

阳离子脂质体DOTAP介导报道基因转染骨关节病滑膜细胞的实验研究 被引量:3

Experimental Study of Cationic Liposome DOTAP-mediated Report Gene Transfection of Osteoarthritis Synovia Cells
原文传递
导出
摘要 目的:探索阳离子脂质体DOTAP介导目的基因转染骨关节病滑膜细胞的最佳条件。方法:分离培养骨关节病滑膜细胞,使用荧光质粒pEGFP-C3作为报道基因,与阳离子脂质体DOPAP一起转染骨关节病滑膜细胞;通过设立不同转染时间组、不同表达时间组以及不同DOTAP剂量组,观察绿色荧光蛋白的表达。结果:使用阳离子脂质体DOTAP介导荧光质粒转染骨关节病滑膜细胞,转染时间在 6h左右, DOTAP(μl)/DNA(μg)比值在 7:1左右,可于转染后48h左右表达出的蛋白量最大。结论:阳离子脂质体DOTAP介导荧光质粒转染骨关节病滑膜细胞转染条件的优化,为今后骨关节病滑膜细胞非病毒基因转移的研究提供实验依据。 To study the optimization of cationic liposome DOTAP-mediated reporter gene transfection of osteoarthritis(OA) synovial cells, we separated and cultured the knee joint synovial cells from OA patients. Cotransfection of synovial cells ~ conducted using fluorescent Plastal PEGal as a reporter gene with cationic liposome DOTAP. For establishing optimal transfection conditions, we designed the techniques of determining the expression level of a reporter protein by varying experimental parameters,such as different transfection time,different expression time and differ- ent ration of DOTAP/DNA,and observed the expression of enhenced green fluorescent protein (EGFP). The result showed that when transfection time was 6 hours and the ratio of DOTAP(ul)/DNA(ug) was 7: 1,the transfection and expression efficiency of synovial cells about 48h after transfection was the highest. We concluded that the optimal transfection conditions of cationic liposome DOTP-mediated reporter gene transfec- tion of OA synovial cells provide experimental evidence for investigating non-viral gene transfer of OA synovial cells.
出处 《中国运动医学杂志》 CAS CSCD 北大核心 1999年第2期106-108,共3页 Chinese Journal of Sports Medicine
关键词 阳离子脂质体 骨关节病 DOTAP 滑膜细胞 转染 Cationic liposome DOTAP, Plasmid pEGFP-C_3,Osteoarthritis, Synovial cell, Transfection
  • 相关文献

参考文献6

共引文献26

同被引文献18

  • 1张灵芝,汤健,唐朝枢.脂质体作为基因载体的研究进展[J].国外医学(分子生物学分册),1993,15(1):10-12. 被引量:7
  • 2Kang R,Marui T,Ghivizzani SC,et al.Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects:A feasibility study[J].Osteoarthritis Cartilage,1997,5:139-143.
  • 3Baragi VM,Renkiewicz RR,Qui L,et al.Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo[J].Osteoarthritis Cartilage,1997,5:275-282.
  • 4Fernandes J,Tardif G,Martel-pelletier J,et al.In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints:Prevention of osteoarthritis progression[J].Am J Pathol,1999,154(4):1159-1169.
  • 5Ikeda T,Kubo T,Arai Y,et al.Adenovirus mediated gene delivery to the joints of guinea pigs[J].J Rheumatol,1998,25(9):1666-1673.
  • 6DD Frisbie,SC Ghivizzani,PD Robbins,et al.Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene[J].Gene Ther,2002,9(1):12-20.
  • 7Bandara G,Robbins PD,Georgecu HI,et al.Gene transfer to synoviocytes:prospects for gene treatment of arthritis[J].DNA Cell Biol,1992,11:227-231.
  • 8顾健人.基因治疗的现状与对策[J].中华医学杂志,1997,77(10):723-724. 被引量:9
  • 9赵京元,于长隆,敖英芳,邱平,刘燕.兔早期骨关节病发病机制研究[J].中国运动医学杂志,1998,17(3):223-230. 被引量:8
  • 10裴明,曲绵域,于长隆,赵文.关节腔内注射裸露DNA治疗关节炎机制的实验研究[J].中国运动医学杂志,1999,18(2):103-105. 被引量:2

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部